Tamura M - Search Results

1

FUT-175, a synthetic inhibitor of the complement pathway, protects against the inactivation of infectious retroviruses by human serum.

Miyao Y, Ikenaka K, Kishima H, Tamura M, Nakamura K, Kurumi M, Hayakawa T, Shimizu K. Miyao Y, et al. Among authors: tamura m. Hum Gene Ther. 1997 Sep 1;8(13):1575-83. doi: 10.1089/hum.1997.8.13-1575. Hum Gene Ther. 1997. PMID: 9322090

2

Gene delivery by HVJ-liposome in the experimental gene therapy of murine glioma.

Mabuchi E, Shimizu K, Miyao Y, Kaneda Y, Kishima H, Tamura M, Ikenaka K, Hayakawa T. Mabuchi E, et al. Among authors: tamura m. Gene Ther. 1997 Aug;4(8):768-72. doi: 10.1038/sj.gt.3300478. Gene Ther. 1997. PMID: 9338004

3

Transduction of glioma cells using a high-titer retroviral vector system and their subsequent migration in brain tumors.

Tamura M, Ikenaka K, Tamura K, Yoshimatsu T, Miyao Y, Kishima H, Mabuchi E, Shimizu K. Tamura M, et al. Among authors: tamura k. Gene Ther. 1998 Dec;5(12):1698-704. doi: 10.1038/sj.gt.3300781. Gene Ther. 1998. PMID: 10023449

4

Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene.

Tamura K, Tamura M, Ikenaka K, Yoshimatsu T, Miyao Y, Nanmoku K, Shimizu K. Tamura K, et al. Among authors: tamura m. Gene Ther. 2001 Feb;8(3):215-22. doi: 10.1038/sj.gt.3301371. Gene Ther. 2001. PMID: 11313793

5

Infectious retrovirus is inactivated by serum but not by cerebrospinal fluid or fluid from tumor bed in patients with malignant glioma.

Shimizu K, Miyao Y, Tamura M, Kishima H, Ohkawa M, Mabuchi E, Yamada M, Hayakawa T, Ikenaka K. Shimizu K, et al. Among authors: tamura m. Jpn J Cancer Res. 1995 Nov;86(11):1010-3. doi: 10.1111/j.1349-7006.1995.tb03013.x. Jpn J Cancer Res. 1995. PMID: 8567389 Free PMC article.

6

Improvement of retroviral packaging cell lines by introducing the polyomavirus early region.

Yoshimatsu T, Tamura M, Kuriyama S, Ikenaka K. Yoshimatsu T, et al. Among authors: tamura m. Hum Gene Ther. 1998 Jan 20;9(2):161-72. doi: 10.1089/hum.1998.9.2-161. Hum Gene Ther. 1998. PMID: 9472776

7

A simplified general method for determination of recombinant retrovirus titers.

Miyao Y, Shimizu K, Tamura M, Yamada M, Tamura K, Nakahira K, Kuriyama S, Hayakawa T, Ikenaka K. Miyao Y, et al. Among authors: tamura k, tamura m. Cell Struct Funct. 1995 Apr;20(2):177-83. doi: 10.1247/csf.20.177. Cell Struct Funct. 1995. PMID: 7641300 Free article.

8

Targeted killing of migrating glioma cells by injection of HTK-modified glioma cells.

Tamura M, Shimizu K, Yamada M, Miyao Y, Hayakawa T, Ikenaka K. Tamura M, et al. Hum Gene Ther. 1997 Mar 1;8(4):381-91. doi: 10.1089/hum.1997.8.4-381. Hum Gene Ther. 1997. PMID: 9054513

9

Usefulness of a mouse myelin basic protein promoter for gene therapy of malignant glioma: myelin basic protein promoter is strongly active in human malignant glioma cells.

Miyao Y, Shimizu K, Tamura M, Akita H, Ikeda K, Mabuchi E, Kishima H, Hayakawa T, Ikenaka K. Miyao Y, et al. Among authors: tamura m. Jpn J Cancer Res. 1997 Jul;88(7):678-86. doi: 10.1111/j.1349-7006.1997.tb00436.x. Jpn J Cancer Res. 1997. PMID: 9310141 Free PMC article.

10

Systemic interleukin 12 displays anti-tumour activity in the mouse central nervous system.

Kishima H, Shimizu K, Miyao Y, Mabuchi E, Tamura K, Tamura M, Sasaki M, Hakakawa T. Kishima H, et al. Among authors: tamura k, tamura m. Br J Cancer. 1998 Aug;78(4):446-53. doi: 10.1038/bjc.1998.513. Br J Cancer. 1998. PMID: 9716025 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,078 results

Search Page

Filters